Q/C Technologies, Inc. (QCLS)
0.50
0.00 (0.00%)
USD |
NASDAQ |
Oct 20, 16:00
0.52
+0.02
(+4.00%)
After-Hours: 06:34
Q/C Technologies EPS Diluted (Quarterly) : -0.794 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.794 |
| March 31, 2026 | -0.1896 |
| December 31, 2025 | -0.8531 |
| September 30, 2025 | -2.503 |
| June 30, 2025 | -17.66 |
| March 31, 2025 | -36.23 |
| December 31, 2024 | -93.23 |
| September 30, 2024 | -1.110 |
| June 30, 2024 | -4.545 |
| March 31, 2024 | -513.84 |
| December 31, 2023 | -2.935 |
| September 30, 2023 | 1.925 |
| June 30, 2023 | -3.376 |
| March 31, 2023 | -1.259 |
| December 31, 2022 | -2.847 |
| September 30, 2022 | -2.838 |
| June 30, 2022 | -2.846 |
| March 31, 2022 | -3.244 |
| December 31, 2021 | -2.58 |
| September 30, 2021 | -4.358 |
| June 30, 2021 | -15.12 |
| March 31, 2021 | -649.26 |
| December 31, 2020 | -11.21 |
| September 30, 2020 | -56.07 |
| June 30, 2020 | -117.18 |
| Date | Value |
|---|---|
| March 31, 2020 | -190.63 |
| December 31, 2019 | -4621.62 |
| September 30, 2019 | -222441.1 |
| June 30, 2019 | -91.57 |
| March 31, 2019 | -105.78 |
| December 31, 2018 | -442.71 |
| September 30, 2018 | -377.05 |
| June 30, 2018 | -255.40 |
| March 31, 2018 | -300.44 |
| December 31, 2017 | -4377.60 |
| September 30, 2017 | -1497.60 |
| June 30, 2017 | -1036.80 |
| March 31, 2017 | -2188.80 |
| December 31, 2016 | -2304.00 |
| September 30, 2016 | 691.20 |
| June 30, 2016 | -2188.80 |
| March 31, 2016 | -3225.60 |
| December 31, 2015 | -7948.80 |
| September 30, 2015 | -5184.00 |
| June 30, 2015 | -4723.20 |
| March 31, 2015 | -2995.20 |
| December 31, 2014 | -2120.95 |
| September 30, 2014 | -2649.60 |
| June 30, 2014 | -1152.00 |
| March 31, 2014 | -1612.80 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
| Johnson & Johnson | 0.0858 |
| Eli Lilly & Co. | 7.939 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.616M |
| Total Expenses (Quarterly) | 6.616M |
| Enterprise Value | -3.393M |
| Earnings Yield | -868.0% |
| Normalized Earnings Yield | -683.22 |